Treasury Starts Application Process for Qualifying Therapeutic Discovery Project Credit

Download IconDownload Print IconPrint

Treasury Starts Application Process for Qualifying Therapeutic Discovery Project Credit

Publication

Related Solutions

A deep and diverse practice focused on maximizing tax efficiencies and minimizing tax risks for clients nationally and internationally.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
Comprehensive counseling for healthcare providers, insurers and the companies that supply them with products and services.
The IRS is now accepting applications for the $1 billion of tax credits/grants available under the qualifying therapeutic discovery project credit program that was mandated by the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act (collectively, the "Affordable Care Act"). Employers may apply for the credit using IRS Form 8942, which the Treasury Department has just released, and applications for the program must be submitted by July 21, 2010.

Here are links to the IRS form and its instructions, as well as the project information memorandum that is part of the application.

Here is a link to our prior alert discussing IRS Notice 2010-45, which provides guidance on the program.

For more information on this or other tax matters, contact A. William Caporizzo. For more information on this or other life sciences matters, contact Cynthia T. Mazareas.

Authors

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel